DSIJ Mindshare

Stock at Rs 1.5: Promoter Plans to Increase Stake by 13%; Secures Rs 100,000,000 Project

Company have announced their intention to increase their stake in the company by up to 13 per cent within the year.

Karan Dsij 1 958 Article rating: 4.0

Financially, this project is expected to generate a gross profit margin of approximately 55-60% of the total order value, translating to an estimated profit between Rs 5.5 to Rs 6 crores.

Promoter bought 12,60,000 shares of this debt-free multibagger penny stock under Rs 2: Company announces strategic business expansion – details inside!

The stock gave multibagger returns of 234 per cent in 3 years and a whopping 475 per cent in 5 years.

Kiran Shroff 0 33465 Article rating: 3.8

Following a recent share purchase by the promoters, their ownership increased to 2.76 per cent, while public ownership decreased slightly to 97.24 per cent.

Promoter acquired 3,00,00,000 equity shares in this penny stock (Rs 6) on warrant conversion!

From Rs 2.66 per share (52-week low) to today’s intraday high of Rs 5.27 per share, the stock is up by 98.12 per cent.

Kiran Shroff 0 1246 Article rating: 4.6

From Rs 2.66 per share (52-week low) to today’s intraday high of Rs 5.27 per share, the stock is up by 98.12 per cent.

1,431 per cent returns: 5,69,800 equity shares allotted to promoter; Solar power plant to set-up from internal accruals- Don’t miss the action in this small-cap stock!

Another noteworthy update is that the company is setting up a solar power plant for captive consumption, with a proposed capacity addition of 400 KWP DC and an investment requirement of Rs.

Karan Dsij 0 6547 Article rating: 4.4

Delivering a remarkable return of 1,431.10 per cent in just the last three years. The returns in the last year are equally impressive, with an advance of 336.76 per cent.

Promoters and FIIs increased stake: This small-cap pharma company targeted Rs 750 crore revenue!

The company plans to launch several new products in the domestic and export markets in Q3 and Q4 of FY24.

Aniket Gogate 0 1491 Article rating: 5.0

FII stake increase: Foreign Institutional Investors (FIIs) have increased their stake in Lincoln Pharma from 0.63 per cent in September 2022 to 2.59 per cent in September 2023.

Promoter holding increase: The promoter holding in Lincoln Pharma has also increased from 44.09 per cent in September 2022 to 50.53 per cent in September 2023.

RSS
12
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR